Navigation Links
Certican in Medical Technology

Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial

...he prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. certican is not approved for use in the US. Afinitor important safety infor...

Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib

...he prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. certican is not approved for use in the US(1). For more information on Afinitor...

RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments

...he prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. certican is not approved in the US. Disclaimer The foregoing release contai...

RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial

...he prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. certican is not approved in the US. In addition to breast cancer, RAD001 is ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

...ilable in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. RAD001 is being evaluated as a single agent or in combination with existing therapies for renal cell ca...

Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer

...ilable in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. In addition to renal cell carcinoma (RCC), RAD001 is being evaluated as a single agent or in combination with ...

RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors

...ilable in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the European Union in 2003. RAD001 is being studied in two large Phase III studies in advanced NETs (pancreatic NET and carcin...

RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer

...ilable in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. In addition to renal cell carcinoma (RCC), RAD001 is being evaluated as a single agent or in combination with ...

Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments

...in the world. Everolimus is approved under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003 and is available in more than 60 countries. About Femara Femara(R) (letrozole tablets) is approved for the ad...

RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer

...in the world. Everolimus is approved under the trade-name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003 and is available in more than 60 countries. Disclaimer The foregoing release contains forward-looking stateme...
Other Tags
(Date:6/30/2015)... , ... June 30, 2015 , ... According to a ... 2007 to 2013 while heroin-related deaths more than tripled in the same period—leading a ... Novus Medical Detox Center , a leading Florida-based drug treatment facility, asserts that ...
(Date:6/30/2015)... , ... June 30, 2015 , ... On June 26, ... Acne ,” listed five triggers that most people would not expect to cause ... and toothpaste. The primary causes of acne are clogged pores and bacteria ...
(Date:6/30/2015)... ... June 30, 2015 , ... Family and professional ... Education Symposium on November 9, 2015 at the Hyatt Regency Denver Tech Center ... with Kim and Ashley Campbell, the wife and daughter of singer Glen Campbell, ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Dr. Sammy Masri ... sports medicine physician. He specializes in the diagnosis and treatment of non-surgical sports and ... the people who participate in recreational athletics and use exercise to stay healthy and ...
(Date:6/30/2015)... ... June 30, 2015 , ... CCAR is pleased to announce its expansion ... Hartford, Willimantic and Bridgeport. This month, staff member Jim Higgins left his role ... He is excited to take on this role of organizing peer recovery support available ...
Breaking Medicine News(10 mins):Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 4Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 5Health News:The Connecticut Community for Addiction Recovery takes Recovery Coaching to a new level 2
(Date:6/17/2015)... PALM BEACH GARDENS, Fla. , June 17, ... identity management solutions, today announced that its U.are.U ... by Togo,s Eateries, Inc., ... based fast casual sandwich chain, to increase security, ... (POS). The Crossmatch fingerprint readers enable instant, non-repudiable identity ...
(Date:6/16/2015)... Sweden , June 16, 2015 ... from previously communicated that it will amount to at least ... MSEK. Due to the rapid increase in market growth and ... the previously communicated guidance that revenue for 2015 will exceed ... will amount to approximately 2,200 MSEK. Due to ...
(Date:6/12/2015)... 2015  Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring, announced the United ... capture, analyze and identify participants of a video ... This system can: , Identify ... subsequent sign-on process is actually the person participating ...
Breaking Biology News(10 mins):Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2
Other Contents